Stevenson K R, Gilmour R S, Wathes D C
Department of Cellular Physiology, AFRC Babraham Institute, Cambridge, United Kingdom.
Endocrinology. 1994 Apr;134(4):1655-64. doi: 10.1210/endo.134.4.8137728.
Insulin-like growth factor-I (IGF-I), IGF-II, and the type 1 IGF receptor (IGF-IR) gene transcripts were localized in sections of ovine uterus collected from 53 ewes at different stages during the estrous cycle and the first 3 weeks of pregnancy using in situ hybridization with synthetic oligonucleotides. Binding studies on cryostat sections using [125I]IGF-I or [125I]des(1-3)IGF-I were carried out to assess whether binding sites for IGF-I colocalized with sites of IGF-IR gene transcription. Peak IGF-I mRNA concentrations occurred at estrus in both the periepithelial endometrial stromal cells and the longitudinal and circular muscle cells of the myometrium. Concentrations of transcript returned to basal levels by 48 h after estrus. The variations in IGF-I mRNA concentration during the estrous cycle showed significant correlations with the estradiol receptor concentration in the same cell types, measured in the same animals by immunocytochemistry (P < 0.01). IGF-II mRNA was localized exclusively to the caruncular stroma (high transcription) and endometrial stroma (low transcription), with levels showing no positive correlation to the concentration of estradiol receptors, progesterone receptors, or plasma progesterone, but decreasing gradually between estrus and days 14-15 (P < 0.05). IGF-IR mRNA was localized mainly to the deep and superficial glandular epithelium, with lower levels of transcription in the caruncular stroma and myometrium. Transcription in the deep glands remained high throughout the cycle, but in the superficial glands and myometrium, a small peak occurred in the early luteal phase (days 1-2), 24-48 h after peak IGF-I gene transcription. [125I]IGF-I- and des(1-3)IGF-I-binding sites colocalized with sites of IGF-IR gene transcription. Additional binding sites were revealed with the iodinated ligands in the myometrium, superficial glands, deep stroma, and blood vessel walls, which were probably attributable to the presence of binding proteins (IGFBPs). The different affinities of des(1-3)IGF-I for IGFBP-3, -2, and -1 lead us to suggest that IGFBP-2 and/or -1 are present in the deep stroma and glands, whereas IGFBP-3 may be responsible for the additional binding sites in the myometrium and blood vessel walls. Comparisons between pregnant and nonpregnant ewes on days 2-15 after estrus did not reveal any clear pregnancy-associated differences in either the sites or levels of IGF-I, IGF-II, or IGF-IR gene transcription.
使用合成寡核苷酸原位杂交技术,对53只母羊在发情周期不同阶段以及妊娠前3周采集的绵羊子宫切片中的胰岛素样生长因子-I(IGF-I)、IGF-II和1型IGF受体(IGF-IR)基因转录本进行定位。利用[125I]IGF-I或[125I]去(1-3)IGF-I对冰冻切片进行结合研究,以评估IGF-I结合位点是否与IGF-IR基因转录位点共定位。在发情期,上皮周围子宫内膜基质细胞以及子宫肌层的纵行和环行肌细胞中IGF-I mRNA浓度达到峰值。发情后48小时,转录本浓度恢复到基础水平。发情周期中IGF-I mRNA浓度的变化与通过免疫细胞化学在相同动物的相同细胞类型中测量的雌二醇受体浓度显著相关(P<0.01)。IGF-II mRNA仅定位于肉阜基质(高转录)和子宫内膜基质(低转录),其水平与雌二醇受体、孕酮受体浓度或血浆孕酮浓度无正相关,但在发情期至第14 - 15天逐渐降低(P<0.05)。IGF-IR mRNA主要定位于深层和浅层腺上皮,肉阜基质和子宫肌层转录水平较低。深层腺体的转录在整个周期中保持较高水平,但在浅层腺体和子宫肌层中,在黄体早期(第1 - 2天),即IGF-I基因转录峰值后24 - 48小时出现一个小峰值。[125I]IGF-I和去(1-3)IGF-I结合位点与IGF-IR基因转录位点共定位。碘化配体在子宫肌层、浅层腺体、深层基质和血管壁中揭示了额外的结合位点,这可能归因于结合蛋白(IGFBPs)的存在。去(1-3)IGF-I对IGFBP-3、-2和-1的不同亲和力使我们推测IGFBP-2和/或-1存在于深层基质和腺体中,而IGFBP-3可能是子宫肌层和血管壁中额外结合位点的原因。对发情后第2 - 15天的怀孕和未怀孕母羊进行比较,未发现IGF-I、IGF-II或IGF-IR基因转录位点或水平上有任何明显的与妊娠相关的差异。